MENU
PCSA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Processa Pharmaceuticals (PCSA) Ownership - Who owns Processa Pharmaceuticals?

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its "regulatory science" approach in the development of Next Generation Chemotherapy ("NGC") oncology drug products... Show more

Profile

Industry
N/A
Address
7380 Coca Cola Drive
Phone
+1 443 776-3133
Employees
13
Web
https://www.processapharmaceuticals.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.42M
P/E Ratio
N/A
Total Cash
1.19M
Projected Growth
N/A
Total Debt
73.51K
Revenue
N/A
Risk (Beta)
1.04
Dividend Yield
N/A
Total Cash/Share
0.23
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

PCSA
Capitalization
1.42M
P/E Ratio
N/A
Risk (Beta)
1.04
Dividend Yield
N/A
Total Cash
1.19M
Total Cash/Share
0.23
Total Debt
73.5K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
1.7M
P/B Ratio
0.84
Cash Flow
N/A
Earnings
-3.87
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
371
Current Ratio
1.22
Current Revenue Per Employee
5000.00
Dividends Per Share - Security
N/A
EBITDA
-12.05M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-262.87
Shares Held By Institutions
109K
Shares Outstanding - Current
5.27M
Total Liabilities
1.53M
Total Volume MTD
N/A
Value
1
Gain YTD
-69.439
View a ticker or compare two or three
PCSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
7380 Coca Cola Drive
Phone
+1 443 776-3133
Employees
13
Web
https://www.processapharmaceuticals.com